Product

Company

NCT03209778·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University Hospital, Strasbourg, France

Age

18–55

Sex

ALL

Healthy volunteers

Accepted

\- for patients only
male or female
age limits : 18-55 years old
under the protection of health insurance
who have signed up the consent form
schizophrenia or schizo-affective disorder according to the DSM-5 criteria (APA, 2013).
clinically stable for at least 2 months
patients under guardianship or curatorship need agreement of their legal representative
informed of the results of prior medical examination for controls only
male or female
age limits : 18-55 years old
under the protection of health insurance
who have sign up the consent form
recruited from the general population and matched on gender, age years of schooling
no psychiatric history (DSM-5)

for both patients and controls
current severe or unstable somatic illness
neurological history (brain injury \> 15 minutes loss of consciousness , epilepsia, brain surgery…)
current substance use disorder (DSM-5)
current major depressive disorder (CDSS,BDI, HDRS)
mental retardation (IQ \< 70, WAIS-4, f-NART)
history of general anesthesia 3 months prior to the experiment
pregnancy declared by the subject
breast feeding
current legal control
in emergency situation
included during exclusion period in another experiment
for controls only
taking of antipsychotic drugs for the 3 weeks prior to inclusion
under guardianship or curatorship

The record

StatusTerminated

PhaseNo phase

Taking part65

StartedSep 2017

UpdatedSep 20, 2021

Conditions

Where1

Clareo Health | Involuntary Memories Investigation in Schizophrenia